These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30327250)

  • 61. Applications of current proteomics techniques in modern drug design.
    Zhang CC; Kast J
    Curr Comput Aided Drug Des; 2010 Sep; 6(3):147-64. PubMed ID: 20438442
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of MAPK and PI3K/AKT signaling pathways on Malabaricone-A induced cytotoxicity in U937, a histiocytic lymphoma cell line.
    Manna A; De Sarkar S; De S; Bauri AK; Chattopadhyay S; Chatterjee M
    Int Immunopharmacol; 2016 Oct; 39():34-40. PubMed ID: 27398613
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proteomics dedicated to biofilmology: What have we learned from a decade of research?
    Khemiri A; Jouenne T; Cosette P
    Med Microbiol Immunol; 2016 Feb; 205(1):1-19. PubMed ID: 26068406
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A method for detecting covalent modification of sensor proteins associated with 1,4-naphthoquinone-induced activation of electrophilic signal transduction pathways.
    Hirose R; Miura T; Sha R; Shinkai Y; Tanaka-Kagawa T; Kumagai Y
    J Toxicol Sci; 2012; 37(5):891-8. PubMed ID: 23037999
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
    Petricoin EF; Bichsel VE; Calvert VS; Espina V; Winters M; Young L; Belluco C; Trock BJ; Lippman M; Fishman DA; Sgroi DC; Munson PJ; Esserman LJ; Liotta LA
    J Clin Oncol; 2005 May; 23(15):3614-21. PubMed ID: 15908672
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A sensitive method for the quantitative measurement of protein thiol modification in response to oxidative stress.
    Landar A; Oh JY; Giles NM; Isom A; Kirk M; Barnes S; Darley-Usmar VM
    Free Radic Biol Med; 2006 Feb; 40(3):459-68. PubMed ID: 16443161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advances in the analysis of dynamic protein complexes by proteomics and data processing.
    Schubert P; Hoffman MD; Sniatynski MJ; Kast J
    Anal Bioanal Chem; 2006 Oct; 386(3):482-93. PubMed ID: 16933131
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Post-translational modification profiling - A novel tool for mapping the protein modification landscape in cancer.
    Eisenberg-Lerner A; Ciechanover A; Merbl Y
    Exp Biol Med (Maywood); 2016 Aug; 241(14):1475-82. PubMed ID: 27229346
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets.
    Goldstein BJ; Mahadev K; Wu X
    Diabetes; 2005 Feb; 54(2):311-21. PubMed ID: 15677487
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peroxisomes and Cellular Oxidant/Antioxidant Balance: Protein Redox Modifications and Impact on Inter-organelle Communication.
    Fransen M; Lismont C
    Subcell Biochem; 2018; 89():435-461. PubMed ID: 30378035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proteomic analysis of cellular signaling.
    Chen WG; White FM
    Expert Rev Proteomics; 2004 Oct; 1(3):343-54. PubMed ID: 15966830
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitative Proteomics Reveals Temporal Proteomic Changes in Signaling Pathways during BV2 Mouse Microglial Cell Activation.
    Woo J; Han D; Wang JI; Park J; Kim H; Kim Y
    J Proteome Res; 2017 Sep; 16(9):3419-3432. PubMed ID: 28777000
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Signaling pathway profiling using reverse-phase protein array and its clinical applications.
    Masuda M; Yamada T
    Expert Rev Proteomics; 2017 Jul; 14(7):607-615. PubMed ID: 28621158
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effective representation and storage of mass spectrometry-based proteomic data sets for the scientific community.
    Olsen JV; Mann M
    Sci Signal; 2011 Feb; 4(160):pe7. PubMed ID: 21325203
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Possibilities of Proteomics Profiling in Predicting Dysfunction of the Cardiovascular System.
    Rusanov VB; Pastushkova LK; Larina IM; Orlov OI
    Front Physiol; 2022; 13():897694. PubMed ID: 35547587
    [No Abstract]   [Full Text] [Related]  

  • 77. Prana and electrons in health and beyond.
    Srinivasan T
    Int J Yoga; 2014 Jan; 7(1):1-3. PubMed ID: 25035600
    [No Abstract]   [Full Text] [Related]  

  • 78. Harmony of Protein Tags and Chimeric Molecules Empowers Targeted Protein Ubiquitination and Beyond.
    Lawer A; Schulz L; Sawyer R; Liu X
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Integrating Phenotypic and Chemoproteomic Approaches to Identify Covalent Targets of Dietary Electrophiles in Platelets.
    Guan IA; Liu JST; Sawyer RC; Li X; Jiao W; Jiramongkol Y; White MD; Hagimola L; Passam FH; Tran DP; Liu X; Schoenwaelder SM; Jackson SP; Payne RJ; Liu X
    ACS Cent Sci; 2024 Feb; 10(2):344-357. PubMed ID: 38435523
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lipoxin A
    Koudelka A; Buchan GJ; Cechova V; O'Brien JP; Liu H; Woodcock SR; Mullett SJ; Zhang C; Freeman BA; Gelhaus SL
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.